Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Beverly Hills. Study-provided care at no cost to qualified participants.
Access macular degeneration specialists in Beverly Hills at no cost
This study follows strict safety protocols and ethical guidelines
All study-related macular degeneration treatment provided free
This is a Phase 1/Phase 2 multicenter study to evaluate the safety and efficacy of a one-time single-eye intravitreal dose of SAR402663 in participants with neovascular age-related macular degeneration. Participants will be enrolled in one of 2 parts: * In Part I (dose escalation), multiple dose levels of SAR402663 will be evaluated in successive cohorts of participants * In Part II (dose expansion), participants will be randomized to receive one of two dose levels selected based on data from
Sponsor: Sanofi
Check if you qualify for this macular degeneration clinical trial in Beverly Hills, CA
If you're searching for macular degeneration treatment options in Beverly Hills, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Beverly Hills research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.